INCY

Incyte Corporation News Headlines

$49.32
*  
0.44
0.9%
Get INCY Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading INCY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter
9/19/2014 11:58:00 AM - Seeking Alpha

Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gilead Most Likely Suitor
9/11/2014 10:49:00 AM - Seeking Alpha

Asian Stocks End Mixed As Chinese Trade Data Counter Overbought Fears
9/8/2014 4:45:00 AM - RTT News

Gilead: Let's Make A Deal
8/28/2014 8:45:00 AM - Seeking Alpha

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape
8/27/2014 8:56:00 AM - Zacks.com

Bullish Two Hundred Day Moving Average Cross - INCY
8/25/2014 4:24:40 PM - BNK Invest

Up Next For Bulls, A Big Test Of Conviction
8/25/2014 11:09:00 AM - Seeking Alpha

ETF Outlook: SPDR S&P Biotech ETF (XBI)
8/13/2014 8:22:34 AM - Marc Chaikin

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha

GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date
8/6/2014 12:02:00 AM - RTT News

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog
8/1/2014 11:17:00 AM - Zacks.com

Sell-Off On Wall Street Drags Dow To Two-Month Low - U.S. Commentary
7/31/2014 12:15:00 PM - RTT News

Incyte Q2 Loss Widens, Boosts 2014 Outlook - Quick Facts
7/31/2014 7:40:00 AM - RTT News

Incyte Q2 14 Earnings Conference Call At 8:30 AM ET
7/31/2014 7:32:00 AM - RTT News

ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners
7/25/2014 10:52:00 AM - Seeking Alpha

Incyte's Jakafi Fails to Provide RELIEF in Polycythemia Vera - Analyst Blog
7/24/2014 6:30:00 PM - Zacks.com

Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
7/21/2014 2:06:00 PM - Seeking Alpha

Incyte (INCY) Enters Oversold Territory - Tale of the Tape
7/16/2014 8:56:21 AM - Zacks.com

Incyte Earns Milestone Payment on Japanese Approval of Jakavi - Analyst Blog
7/9/2014 6:50:00 PM - Zacks.com

Incyte Earns $25 Mln Milestone Payment From Novartis On Jakavi Approval In Japan
7/8/2014 7:42:00 AM - RTT News

Moving Average Crossover Alert: Incyte (INCY) - Tale of the Tape
7/2/2014 9:39:18 AM - Zacks.com

Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
6/30/2014 10:47:00 AM - Seeking Alpha

Incyte To Present At JMP Securities Conference; Webcast At 11:00 AM ET
6/25/2014 10:00:00 AM - RTT News

Fire Up The Immuno-Oncology Powerhouses: John McCamant
6/19/2014 5:39:00 PM - Seeking Alpha

Merck KGaA & MorphoSys Sign Deal, Immuno-Oncology in Focus - Analyst Blog
6/12/2014 4:30:00 PM - Zacks.com